share_log

Altamira Therapeutics FY EPS $(16.47) Sales $284.47K Down From $330.37K YoY

Moomoo 24/7 ·  Apr 10 09:21

Altamira Therapeutics (NASDAQ:CYTO) reported quarterly losses of $(16.47) per share. This is a 97.38 percent increase over losses of $(629.80) per share from the same period last year. The company reported $284.47 thousand in sales this quarter. This is a 13.89 percent decrease over sales of $330.37 thousand the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment